跳至主要内容
临床试验/NCT04930029
NCT04930029招募中不适用

Evaluation of Long-term Adverse Effects of Gastric Bypass in Omega

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2021年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
320
试验地点
1
主要终点
Incidence of serious surgery-related adverse events

研究概览

简要总结

The omega gastric bypass (OAGB) is developing worldwide as an alternative to the Y gastric bypass (RYGB). Cases of nutrition deficiency after OAGB, in particular protein deficency, are regularly reported in the literature, raising the question of the medium/long-term safety of this procedure. In its technology assessment report issued in September 2019 (HAS, 2019), the Haute Autorité de Santé rules on the invalidity of OAGB with a 200 cm biliary limb and the lack of sufficient data on the safety of OAGB with a 150 cm biliary limb compared to RYGB. The lack of long-term data on weight, resolution of comorbidities, quality of life, and endoscopic evaluation given the risk of lower esophageal cancer is also noted.

The main objective of the study is to compare the incidence of serious adverse events related to surgery after OAGB at 10 years, according to 2 types of loop: a realization with a 150-cm biliary loop (OAGB AB150) versus a realization with a 200-cm biliary loop (OAGB AB200).

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who received 10 ± 2 years ago (between 2009 and 2013) an OAGB with a 150 or 200cm biliary limb. Patients should be consecutive at each center.
  • Patients fulfilling the criteria of indication for bariatric surgery at the time of their intervention according to the recommendations of the HAS (HAS, 2009) in an expert center.
  • Patients agreeing to perform an endoscopic evaluation with biopsies at 10 years
  • Patients who gave their consent
  • Patients with health insurance coverage

排除标准

  • Contraindication to bariatric surgery defined according to HAS recommendations (HAS, 2009)
  • Persons deprived of liberty, under guardianship, or under curatorship
  • Patients included in a protocol with a conflict of interest with OMEGA10.

结局指标

主要结局

Incidence of serious surgery-related adverse events

时间窗: 10 years after surgery

A serious adverse event is defined as a medical event that requires hospitalization, is life-threatening, results in persistent or substantial disability, or results in death. The "surgery-related" character will be described by each investigator in the first instance and homogenized by the group of experts designated at the beginning of the study.

次要结局

  • Dyslipidemia remission(10 years after surgery)
  • Obstructive sleep apnea remission(10 years after surgery)
  • GERD(10 years after surgery)
  • Nutritional biological status , assessed by evaluation of malnutrition parameters(10 years after surgery)
  • Diabetes remission(10 years after surgery)
  • Quality of life by GIQLI score (Gastro Intestinal Quality of Life index) questionnaires(10 years after surgery)
  • Excess weight loss percentage(10 years after surgery)
  • incidence of serious adverse events not related to surgery(10 years after surgery)
  • Quality of life by BAROS score (Bariatric analysis and reporting outcome system)(10 years after surgery)
  • Nutritional clinical status, assessed by dietitian evaluation(10 years after surgery)
  • Metabolic comorbidities remission(10 years after surgery)
  • Hypertension remission(10 years after surgery)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验